You have read all your free articles, to continue reading subscribe to read the rest of this content.
Antaros Medical, has entered into a research agreement with SANOFI. The project seeks to increase the understanding of the activity of certain incretins and underscores the vital role Antaros Medical plays as a trusted partner to major drug manufacturers. “The Antaros team has an impressive traAlready a subscriber Login You…
Imfinzi has been approved in Japan for the treatment of patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with etoposide plus a choice of platinum chemotherapy (either carboplatin or cisplatin). SCLC is a highly aggressive, fast-growing form of lung cancer that typicaAlready a subscriber Login You have read…
The Swedish/Danish biotech company 2A Pharma has closed its first financing round and has been granted an exclusive, worldwide license from Medigene for its adeno-associated virus like particles (AAVLPs) technology. 2A Pharma AB, based in Malmö, Sweden with research facilities in Aalborg, DenmarAlready a subscriber Login You have read all…
Calliditas Therapeutics announced in July that the European Commission (EC) has granted conditional marketing authorization for Kinpeygo for the treatment of primary immunoglobulin A (IgA) nephropathy (IgAN) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (UPCAlready a subscriber Login You have read all your free…
